Dalliance Pharmaceuticals Llp - Company Profile

It is a pharma limited liability partnership based in Faridabad, Haryana, India, established in 2020.
2020 Faridabad, Haryana, India Active
Last Updated:
Access Report
About Dalliance Pharmaceuticals Llp

Dalliance Pharmaceuticals Llp, a active limited liability partnership, was established on 29 May 2020 in Faridabad, Haryana, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAS-5115. Registered under ROC Roc Delhi. It has total obligation of contribution of ₹1.20 M.

Its leadership includes Radha Krishna Agrawal (Designated Partner), Niti Agrawal (Designated Partner). It holds ₹24.00 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at C 1052, Sainik Colony Sector 49, Faridabad, Haryana, 121003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAS-5115

  • Incorporation Date

    29 May 2020

  • Total Obligation of Contribution

    ₹1.20 M

  • ROC Code

    Roc Delhi

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 1.20 M
  • Company Age 5 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 24.00 Cr
Company report

Dalliance Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dalliance Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dalliance Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Radha Krishna Agrawal Designated Partner 29 May 2020 Current
Niti Agrawal Designated Partner 29 May 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dalliance Pharmaceuticals Llp.

Enhance accessibility to Dalliance Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dalliance Pharmaceuticals Llp revenue growth over time
Dalliance Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dalliance Pharmaceuticals Llp?

Unlock access to Dalliance Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹240,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 24.00 Cr
Latest Charge Details
Date Lender Amount Status
10 Jan 2022 State Bank Of India ₹24.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Dalliance Pharmaceuticals Llp?

Unlock and access historical data on people associated with Dalliance Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dalliance Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dalliance Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dalliance Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Dalliance Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Dalliance Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Charges

    A charge with State Bank Of India of Rs. 240.00 M registered on 10 Jan 2022 with Charge ID 100535525 was modified on 19 Aug 2022. was recorded as a recent event.

  • Charges

    A charge with State Bank Of India amounted to Rs. 240.00 M with Charge ID 100535525 was registered on 10 Jan 2022. was recorded as a recent event.

  • Director Appointment

    Progress on Radha Krishna Agrawal was appointed as a Designated Partner was appointed as a Designated Partner on 29 May 2020 & has been associated with this company since 5 years 8 months . was documented.

  • Director Appointment

    Progress on Niti Agrawal was appointed as a Designated Partner was appointed as a Designated Partner on 29 May 2020 & has been associated with this company since 5 years 8 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Dalliance Pharmaceuticals Llp?

The LLPIN of Dalliance Pharmaceuticals Llp is AAS-5115.

Where is Dalliance Pharmaceuticals Llp headquartered?

Dalliance Pharmaceuticals Llp is headquartered at C 1052, Sainik Colony Sector 49, Faridabad, Haryana, 121003.

When was Dalliance Pharmaceuticals Llp incorporated?

Dalliance Pharmaceuticals Llp was incorporated on 29 May 2020.

Who are the current directors of Dalliance Pharmaceuticals Llp?

The current directors of Dalliance Pharmaceuticals Llp are

What is the primary industry of Dalliance Pharmaceuticals Llp?

The primary industry of Dalliance Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available